Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

被引：530

作者：

Schnipper, Lowell E. ^{[1
]}

Davidson, Nancy E. ^{[4
,5
]}

Wollins, Dana S. ^{[7
]}

Blayney, Douglas W. ^{[8
]}

Dicker, Adam P. ^{[6
]}

Ganz, Patricia A. ^{[9
]}

Hoverman, J. Russell ^{[11
]}

Langdon, Robert ^{[12
]}

Lyman, Gary H. ^{[14
,15
]}

Meropol, Neal J. ^{[16
,17
]}

Mulvey, Therese ^{[2
]}

Newcomer, Lee ^{[18
]}

Peppercorn, Jeffrey ^{[2
]}

Polite, Blase ^{[19
]}

Raghavan, Derek ^{[20
]}

Rossi, Gregory ^{[21
]}

Saltz, Leonard ^{[22
]}

Schrag, Deborah ^{[3
]}

Smith, Thomas J. ^{[23
]}

Yu, Peter P. ^{[10
]}

Hudis, Clifford A. ^{[22
]}

Vose, Julie M. ^{[13
]}

Schilsky, Richard L. ^{[7
]}

机构：

[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA

[2] Massachusetts Gen Hosp, Boston, MA 02114 USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[5] Univ Pittsburgh, Med Ctr, Ctr Canc, Pittsburgh, PA USA

[6] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA

[7] Amer Soc Clin Oncol, Alexandria, VA USA

[8] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[9] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA

[10] Palo Alto Med Fdn, Palo Alto, CA USA

[11] Texas Oncol, Dallas, TX USA

[12] Nebraska Canc Specialists, Omaha, NE USA

[13] Univ Nebraska Med Ctr, Omaha, NE USA

[14] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[15] Univ Washington, Seattle, WA 98195 USA

[16] Univ Hosp Cleveland, Case Med Ctr, Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA

[17] Case Western Reserve Univ, Cleveland, OH 44106 USA

[18] UnitedHealthcare, Minneapolis, MN USA

[19] Univ Chicago, Med, Chicago, IL 60637 USA

[20] Levine Canc Inst, Charlotte, NC USA

[21] AstraZeneca, Macclesfield, Cheshire, England

[22] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[23] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 24期

关键词：

PLUS ADJUVANT CHEMOTHERAPY; PROSTATE-CANCER; BREAST-CANCER; ENZALUTAMIDE; TRIAL;

D O I：

10.1200/JCO.2016.68.2518

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2925 / +

页数：14

共 13 条

[1]

[Anonymous], DRUG PRIC POL

[2] Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia [J].

Burger, J. A. ;

Tedeschi, A. ;

Barr, P. M. ;

Robak, T. ;

Owen, C. ;

Ghia, P. ;

Bairey, O. ;

Hillmen, P. ;

Bartlett, N. L. ;

Li, J. ;

Simpson, D. ;

Grosicki, S. ;

Devereux, S. ;

McCarthy, H. ;

Coutre, S. ;

Quach, H. ;

Gaidano, G. ;

Maslyak, Z. ;

Stevens, D. A. ;

Janssens, A. ;

Offner, F. ;

Mayer, J. ;

O'Dwyer, M. ;

Hellmann, A. ;

Schuh, A. ;

Siddiqi, T. ;

Polliack, A. ;

Tam, C. S. ;

Suri, D. ;

Cheng, M. ;

Clow, F. ;

Styles, L. ;

James, D. F. ;

Kipps, T. J. ;

Keating, Michael ;

Jen, Jie ;

Jindra, Pavel ;

Simkovic, Martin ;

Braester, Andrei ;

Ruchlemer, Rosa ;

Foa, Roberto ;

Semenzato, Gianpietro ;

Hawkins, Timothy ;

Atanasio, Carolina Moreno ;

Demirkan, Fatih ;

Kaynar, Leylagul ;

Pylypenko, Halyna ;

Fox, Christopher ;

Thirman, Michael ;

Campbell, Philip .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) :2425-2437

[3]

Centers for Medicare and Medicaid Services, 2016 ASP DRUG PRIC F

[4] A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) [J].

Cherny, N. I. ;

Sullivan, R. ;

Dafni, U. ;

Kerst, J. M. ;

Sobrero, A. ;

Zielinski, C. ;

de Vries, E. G. E. ;

Piccart, M. J. .

ANNALS OF ONCOLOGY, 2015, 26 (08) :1547-1573

[5] Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial [J].

Eggermont, Alexander M. M. ;

Chiarion-Sileni, Vanna ;

Grob, Jean-Jacques ;

Dummer, Reinhard ;

Wolchok, Jedd D. ;

Schmidt, Henrik ;

Hamid, Omid ;

Robert, Caroline ;

Ascierto, Paolo A. ;

Richards, Jon M. ;

Lebbe, Celeste ;

Ferraresi, Virginia ;

Smylie, Michael ;

Weber, Jeffrey S. ;

Maio, Michele ;

Konto, Cyril ;

Hoos, Axel ;

de Pril, Veerle ;

Gurunath, Ravichandra Karra ;

de Schaetzen, Gaetan ;

Suciu, Stefan ;

Testori, Alessandro .

LANCET ONCOLOGY, 2015, 16 (05) :522-530

[6] Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial [J].

Fizazi, Karim ;

Scher, Howard I. ;

Miller, Kurt ;

Basch, Ethan ;

Sternberg, Cora N. ;

Cella, David ;

Forer, David ;

Hirmand, Mohammad ;

de Bono, Johann S. .

LANCET ONCOLOGY, 2014, 15 (10) :1147-1156

[7]

Institute for Clinical and Economic Review, SCOP DOC ICER REV DR

[8]

Memorial Sloan Kettering Cancer Center, EV DRIV DRUG PRIC PR

[9]

*NAT COMPR CANC NE, NCCN CLIN PRACT GUID

[10] Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31 [J].

Perez, Edith A. ;

Romond, Edward H. ;

Suman, Vera J. ;

Jeong, Jong-Hyeon ;

Davidson, Nancy E. ;

Geyer, Charles E., Jr. ;

Martino, Silvana ;

Mamounas, Eleftherios P. ;

Kaufman, Peter A. ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) :3366-3373

← 1 2 →